According to MyMD Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ8.30. In 2022 the company made an earnings per share (EPS) of -ยฃ8.75 an increase over its 2021 EPS that were of -ยฃ19.08.